Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: March 30, 2007
In 2003 Congress passed the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act, which established a five-year, $15 billion initiative to help countries around the world respond to their AIDS epidemics. The initiative is generally referred to by the title of the five-year strategy required by the act—PEPFAR, or the President’s Emergency Plan for AIDS Relief.
Released: March 29, 2007
An IOM committee was convened to review biomarker research, development, and implementation. The committee was asked to examine questions regarding the discovery, development, adoption, and use of biomarkers for cancer screening, diagnosis, and treatment, with the goal of identifying obstacles to progress that could potentially be overcome through policy changes.
Released: March 22, 2007
The IOM's National Cancer Policy Forum sponsored a public workshop addressing several issues related to cancer and aging; including cancer rehabilitation, increased prevalence of cancer survivors, end of life care, the role of nurses, and Medicare costs in geriatric oncology.
Released: February 01, 2007
Cancer is generally low or absent on the health agenda of most the world’s low- and middle-income countries (LMCs), even as it is growing as a share of these countries’ overall disease burden. In light of this situation, the National Cancer Institute and the American Cancer Society asked the Institute of Medicine to study the issue and provide an assessment and recommendations to tackle the problem.
Released: December 22, 2006
The IOM Committee on Cancer Survivorship: Improving Care and Quality of Life concluded in their 2006 report "From Cancer Patient to Cancer Survivor: Lost in Transition" that cancer survivorship is a distinct phase of the cancer trajectory and that a strategy is needed for the ongoing clinical care of cancer survivors. As a follow-up to the report, the National Cancer Policy Forum of the Institute of Medicine (IOM) held a workshop, "Implementing Cancer Survivorship Care Planning" May 15-16 in DC.
Released: December 11, 2006
Computer models and analyses of past flu outbreaks indicate that there is a role for community-wide intervention -- such as isolating infected people or voluntary quarantine -- to control illnesses and deaths during the next pandemic flu, says a new report from the Institute of Medicine. It adds, however, that government and community leaders should not overstate the certainty about their effectiveness.
Released: November 06, 2006
Amyotrophic lateral sclerosis (ALS), sometimes known as Lou Gehrig’s disease, is a progressive and nearly always fatal disease that affects a person’s nervous system. Several recent epidemiologic studies have reported an association between development of ALS and prior service in the US military. The Department of Veterans Affairs asked the Institute of Medicine to conduct an independent assessment of the potential relationship between military service and ALS. Amyotrophic Lateral Sclerosis in Veterans: Review of the Scientific Literature reports that there is limited and suggestive evidence of an association between military service and later development of ALS.
Released: November 03, 2006
In 1998, the IOM began a series of congressionally-mandated studies to examine the scientific and medical literature on the potential health effects of chemical and biological agents related to the 1991 Gulf War. Gulf War and Health: Volume 5. Infectious Disease, evaluates, and summarizes the peer-reviewed scientific and medical literature on long-term adverse human health effects associated with selected infectious diseases pertinent to Gulf War veterans. The infectious diseases include, but are not limited to, diseases caused by pathogenic Escherichia coli, shigellosis, leishmaniasis, and sandfly fever.
Released: September 15, 2006
The sharing of contaminated injecting equipment has become a driving force behind the global AIDS epidemic and is the primary mode of HIV transmission in many countries, particularly throughout Eastern Europe, the Commonwealth of Independent States, and significant parts of Asia. In response to this crisis, in 2005 the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the Bill & Melinda Gates Foundation commissioned the Institute of Medicine to evaluate strategies for preventing HIV transmission among injecting drug users.
Released: June 23, 2006
The Institute of Medicine's Forum on Microbial Threats hosted the public workshop Ending the War Metaphor: The Future Agenda for Unraveling the Host-Microbe Relationship, aimed to inform the Forum, the public, and policymakers of the dynamic host-microbe-environment relationships.